Ausgabe 4/2019
Inhalt (12 Artikel)
Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions
José A. Sacristán, Silvia Díaz, Inmaculada de la Torre, José Inciarte-Mundo, Alejandro Balsa
New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review
Fabio Massimo Perrotta, Antonio Musto, Ennio Lubrano
Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap
Atul Deodhar, Lianne S. Gensler, Marina Magrey, Jessica A. Walsh, Adam Winseck, Daniel Grant, Philip J. Mease
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study
Mark C. Genovese, Maria W. Greenwald, Sergio R. Gutierrez-Ureña, Mario H. Cardiel, Jeffrey E. Poiley, Anna Zubrzycka-Sienkiewicz, Christine E. Codding, Annie Wang, Weizhong He, Rebecca Amos, Raul Vinueza, Xuegong Wang, Jay P. Garg, Alan J. Kivitz
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
Ennio Lubrano, Fabio Massimo Perrotta, Silvia Scriffignano, Laura C. Coates, Philip Helliwell
Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries
Philip J. Mease, Mei Liu, Sabrina Rebello, Hyungjoo Kang, Esther Yi, Yujin Park, Jeffrey D. Greenberg
A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout
Fengchun Zhang, Zhichun Liu, Lindi Jiang, Hao Zhang, Dongbao Zhao, Yang Li, Hejian Zou, Xiaoyue Wang, Xiangpei Li, Bingyin Shi, Jianhua Xu, Hongjie Yang, Shaoxian Hu, Shen Qu
Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE)
Roy Fleischmann, Michael Weinblatt, Harris Ahmad, Michael A. Maldonado, Evo Alemao, June Ye, Michael Schiff
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
George W. Reed, Robert A. Gerber, Ying Shan, Liza Takiya, Kimberly J. Dandreo, David Gruben, Joel Kremer, Gene Wallenstein
Physical and Emotional Burden of Rheumatoid Arthritis: Data from RA Matters, a Web-Based Survey of Patients and Healthcare Professionals
Rieke Alten, Mart van de Laar, Francesco De Leonardis, Nicole Tietz, Mariana Guerreiro, Ronald van Vollenhoven
Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database
Jennie H. Best, Amanda M. Kong, Sebastian Unizony, Oth Tran, Margaret Michalska
Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis
Siyeon Park, Tham T. Le, Julia F. Slejko, Ester Villalonga-Olives, Eberechukwu Onukwugha